FindTrial
Sign In

Ropivacaine Instillation Through Subgaleal Drain: An Effective Approach to Post-Craniotomy Pain Relief

A Study of efficacy of Ropivacaine Instillation Through Subgaleal Drain for Post Craniotomy Pain Management A Randomized Controlled Trial - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099630
Enrollment
46
Registered
2025-12-22
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: instillation of inj ropivacaine through subgaleal drain for post craniotomy pain management: All patients included in the study will undergo a standard preoperative assessment and will

Sponsors

Dr AKHIL A G
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adults aged 18 to 70 years Patients undergoing supratentorial craniotomy ASA physical status I to III

Exclusion criteria

Exclusion criteria: Gcs less than 12 Allergic to local anesthetic Previous history of brain surgery

Design outcomes

Primary

MeasureTime frame
To assess postoperative pain scores using the Visual Analog Scale (VAS) at predefined time intervals (1,4,8,10,12, 24 hours) o To evaluate the time to first rescue analgesia postoperativelyTimepoint: time intervals 1,4,8,10,12, 24 hour—

Secondary

MeasureTime frame
To assess total number of analgesics consumption within the first 24 hours postoperatively o To assess Richmond Agitation Sedation Score (RASS) and Modified Aldrete score (MAS) at the intervals of (1,4,8,10,12,24 hoursTimepoint: Time interval 1,4,8,10,12,24hours—

Countries

India

Contacts

Public ContactDr SRIDEVI M MULIMANI

Shri B M patil medical college hospital and research centre

sridevi.mulimani@bldedu.ac.in9449534216

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026